Reprogrammed Stem Cells Are Rife with Mutations
By Emily Singer,
Technology Review
| 03. 03. 2011
The findings cast doubt on a promising alternative to the use of embryonic stem cells in medicine.
Adult cells that have been reprogrammed into stem cells harbor a number of genetic mutations, some of which appear in genes that have been linked to cancer. While scientists don't yet know how this might affect the use of the cells in medicine, they say the findings show that the cells need to be studied much more extensively.
"As we think about using [these] cells for therapy, we will want to consider what kinds of screening tests we want to do," says Lawrence Goldstein, a professor of molecular biology at the University of California, San Diego. One of the major concerns about stem-cell-based therapies has been whether they carry a risk of cancer; both stem cells and cancer cells are distinguished by their ability to continually divide.
In two studies published today in Nature, researchers analyzed the genome of induced pluripotent stem (iPS) cells, adult cells that have been genetically or chemically reverted to the stem cell state. These cells have attracted intense interest from both scientists and the public as a potential alternative to embryonic stem cells. Like...
Related Articles
By Christina Jewett, The New York Times | 11.12.2024
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...
By Jocelyn Kaiser , Science | 10.09.2024
Rare and fatal, the genetic disease known as cerebral adrenoleukodystrophy (ALD) devastates the brain in young boys. A mutation on the X chromosome leads to a buildup of fats that damage the insulation around nerve cells, leading to seizures, blindness...
By Don Sapatkin, Managed Healthcare Executive | 09.20.2024
Gene therapy comes with the expectation that it will “cure” an expanding number of genetic disorders. If you’ve never wondered – and even if you have -- what that word actually means, four Dutch researchers have a surprise in store...